LongTec China Ventures
3
15M
3
2
- Areas of investment
Summary
The main department of described VC is located in the Shanghai. The venture was found in Asia in China.
The high activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year.
The fund was created by Peggy Wang.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the LongTec China Ventures, startups are often financed by OrbiMed, GE Ventures, Fosun Group. The meaningful sponsors for the fund in investment in the same round are OrbiMed, HOYA CORPORATION, GE Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.
Among the most successful fund investment fields, there are Virtual Reality, Biotechnology. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Ornim Medical, RealView Imaging, 3NT Medical The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 2
- Investments by industry
- Health Care (3)
- Medical Device (2)
- Biotechnology (1)
- Neuroscience (1)
- Virtual Reality (1) Show 2 more
- Investments by region
-
- Israel (3)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 3NT Medical | 08 May 2018 | Health Care, Medical Device, Medical | Late Stage Venture | 15M | Israel, North District |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.